Cite Filings / BEAM / 0001104659-26-009583

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Beam Therapeutics Inc. Filed 2026-02-03 Acc 0001104659-26-009583

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-02-05 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-03 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-02 4 Options or other derivatives
2026-02-02 4 Options or other derivatives
2026-02-02 4 Options or other derivatives
2026-02-02 4 CEO sold 50,000 shares at an average $28.87 ($1,443,528)
2025-11-05 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…